Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort SMART vs Symbicort plus terbutaline in asthma
NCT00839800Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Feb 2009; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00839800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839800.